tofacitinib and Skin-Diseases--Vascular

tofacitinib has been researched along with Skin-Diseases--Vascular* in 2 studies

2 other study(ies) available for tofacitinib and Skin-Diseases--Vascular

Article	Year
Tofacitinib for the treatment of refractory or glucocorticoid-dependent cutaneous leukocytoclastic vasculitis. Dermatologic therapy, 2022, Volume: 35, Issue:11 Topics: Glucocorticoids; Humans; Piperidines; Skin Diseases, Vascular; Vasculitis, Leukocytoclastic, Cutaneous	2022
Refractory ulcerations associated with livedoid vasculopathy successfully treated with tofacitinib. Dermatologic therapy, 2020, Volume: 33, Issue:6 Topics: Humans; Livedo Reticularis; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Skin Diseases, Vascular; Skin Ulcer; Vascular Diseases	2020